| 序号 | 标题 | 次数 | 作者 | 发布时间 |
|---|---|---|---|---|
| 87121 | CRISPRa基因过表达技术，CRISPR/Cas9系统 | 567 | axc | 2024-12-13 |
| 87122 | HS-(CH2)11-PEG3-OH 巯基-长链烷基 -三聚乙二醇 | 175 | zcy | 2024-12-13 |
| 87123 | (S)-PROTAC PTK6 ligand-1-(2S,4R)-O-CH2-O-hygric acid | 203 | zyl | 2024-12-13 |
| 87124 | Pebac; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone; D-Phe-Pro-Arg-CH2Cl | 402 | zcy | 2024-12-13 |
| 87125 | Ms-PEG3-CH2CH2COOH | 183 | zyl | 2024-12-13 |
| 87126 | m-PEG5-CH2CH2COOH | 177 | zyl | 2024-12-13 |
| 87127 | miRNA过表达稳定细胞系的构建方法 | 700 | axc | 2024-12-13 |
| 87128 | Fmoc-NH-PEG2-CH2CH2COOH | 211 | zyl | 2024-12-13 |
| 87129 | miRNA过表达稳定细胞系的发现及其机制 | 300 | axc | 2024-12-13 |
| 87130 | m-PEG6-CH2CH2CHO | 148 | zyl | 2024-12-13 |
| 87131 | MAK683-CH2CH2COOH | 214 | zyl | 2024-12-13 |
| 87132 | (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc | 173 | zyl | 2024-12-13 |
| 87133 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc | 117 | zyl | 2024-12-13 |
| 87134 | MC-VC-PABC-amide-PEG1-CH2-CC-885 | 113 | zyl | 2024-12-13 |
| 87135 | Azido-PEG4-(CH2)3OH | 149 | zyl | 2024-12-13 |
| 87136 | 慢病毒载体的来源及结构，构建慢病毒表达载体 | 1164 | axc | 2024-12-13 |
| 87137 | Ald-CH2-PEG8-azide | 172 | zyl | 2024-12-13 |
| 87138 | m-PEG4-(CH2)6-Phosphonic acid | 151 | zyl | 2024-12-13 |
| 87139 | Ald-CH2-PEG5-Boc | 130 | zyl | 2024-12-13 |
| 87140 | 通过构建shRNA慢病毒质粒实现基因的敲减，慢病毒载体的发展过程 | 1054 | axc | 2024-12-13 |
| 87141 | Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH | 162 | zyl | 2024-12-13 |
| 87142 | Gly-NH-CH2-Boc | 192 | zyl | 2024-12-13 |
| 87143 | Difluorocyclooctyne-CH2-benzoic acid | 173 | zyl | 2024-12-13 |
| 87144 | NH2-PEG2-CH2-Boc | 172 | zyl | 2024-12-13 |
| 87145 | shRNA慢病毒载体构建及细胞系筛选 | 563 | axc | 2024-12-13 |
| 87146 | Hydroxy-PEG4-(CH2)2-Boc | 139 | zyl | 2024-12-13 |
| 87147 | Thalidomide-5-O-CH2-COOH | 162 | zyl | 2024-12-13 |
| 87148 | Thalidomide-NH-CH2-COOH | 176 | zyl | 2024-12-13 |
| 87149 | Amino-PEG10-CH2-Boc | 185 | zyl | 2024-12-13 |
| 87150 | Hydroxy-PEG6-CH2-Boc | 128 | zyl | 2024-12-13 |
| 87151 | Tos-PEG4-CH2-Boc | 137 | zyl | 2024-12-13 |
| 87152 | m-PEG4-CH2-alcohol | 124 | zyl | 2024-12-13 |
| 87153 | β-Naphthoflavone-CH2-OH | 185 | zyl | 2024-12-13 |
| 87154 | 利用慢病毒快速构建IPS稳转株，定制服务 | 201 | axc | 2024-12-13 |
| 87155 | Methyl isonicotinate-(CH2)2-COOH | 137 | zyl | 2024-12-13 |
| 87156 | HO-PEG24-CH2COOtBu | 124 | zyl | 2024-12-13 |
| 87157 | Hydroxy-PEG10-CH2-Boc | 174 | zyl | 2024-12-13 |
| 87158 | Fmoc-Gly-NH-CH2-acetyloxy | 140 | zyl | 2024-12-13 |
| 87159 | Thalidomide-5-CH2-NH2 hydrochloride | 156 | zyl | 2024-12-13 |
| 87160 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH-d5 | 135 | zyl | 2024-12-13 |
| 87161 | 通过慢病毒介导的基因过表达，定制服务，实验步骤 | 325 | axc | 2024-12-13 |
| 87162 | 基因敲低、敲除、过表达载体的构建 | 1979 | axc | 2024-12-13 |
| 87163 | 质粒以及慢病毒的基因过表达方法 | 1238 | axc | 2024-12-13 |
| 87164 | CRISPR KI技术构建基因过表达细胞株 | 484 | axc | 2024-12-13 |
| 87165 | CRISPRa系统构建基因过表达细胞株，CRISPRa技术优势 | 450 | axc | 2024-12-13 |
订单热线
400-6966-012
齐岳微信公众号
官方微信All Rights Reserved 陕ICP备20008861号
技术支持：硅峰网络
库存查询